Paragon 28(FNA) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Paragon 28 Reports Third Quarter 2024 Financial Results and Raises 2024 Net Revenue Guidance ENGLEWOOD, CO., November 12, 2024 -- Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended September 30, 2024 and raised its 2024 net revenue guidance. Recent Business Updates ● Recorded global net revenue of $62.3 million in the third quarter, represen ...